EFDID: 405202EFD: View Filing

Issuer: Petros Pharmaceuticals, Inc. (0001815903) - D

Accession: 0001104659-21-129900 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001815903
  • Entity Name:
    Petros Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2020)
  • Address:
    1185 AVENUE OF THE AMERICAS, SUITE 249
    NEW YORK, NY 10036
  • Persons:
    Related Persons 8
    Mitchell Arnold
    Executive Officer 
    Vice President of Finance and Principal Accounting Officer
    Fady Boctor
    Executive Officer 
    President and Chief Commercial Officer
    John D. Shulman
    Director
    Joshua N. Silverman
    Director
    Bruce T. Bernstein
    Director
    Gregory Bradley
    Director
    Wayne R. Walker
    Director
    Andrew Gesek
    Executive Officer 
    President, Timm Medical
EDGAR: Offering Information
  • Accession Date:
    10/26/2021
  • First Sale Date:
    10/13/2021
  • Offering Amount:
    $5,922,951
  • Amount Sold:
    $0
  • Amount Remaining:
    $5,922,951
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    Represents warrants to purchase up to 3,323,616 shares of common stock at $1.715/share and warrants to purchase up to 130,000 shares of common stock at $1.715/share issued to financial advisors in connection with RD offering that closed on 10/15/2021.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CT
Inactive:IL, NY
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Petros Pharmaceuticals, Inc./s/ Mitchell ArnoldMitchell ArnoldVice President of Finance and Principal Accounting Officer2021-10-22